News

Catch up on acne vulgaris treatment pearls from Dermatology Times’ most recent Frontline Forum series, featuring James Del Rosso, DO; Hilary Baldwin, MD; Neal Bhatia, MD; Christopher Bunick, MD, PhD; and Leon Kircik, MD.

This Skin Care Awareness Month, Dermatology Times wants to hear your insights. Click here to answer this week's poll.

Apremilast treatment for psoriasis and psoriatic arthritis can be managed effectively through telehealth visits.

Keep up with the latest headlines in dermatology from the past week, including excimer laser market projections, an innovative skin health app developed by a California teenager, and more.

ICYMI, this week we had articles about lowered infection risks with IL23i and IL-17i, a new trio combination cream for melasma treatment, tralokinumab's success among older patients with AD, and more.

In the cohort trial, 85% of patients showed an improvement of more than 50 on PASI.

Quality of life and sexuality were somewhat affected in 51.9% of adults who had been diagnosed with vulvar lichen sclerosus in childhood or adolescence.

Click here to answer this week’s poll.

Both modalities achieved positive results and accurate ablation in cultured epithelial sheets transplantation for patients with vitiligo.

Learn more about the in-depth topics covered in the August 2023 Frontline Forum acne vulgaris supplement of Dermatology Times.

Patricia Farris, MD, and Ted Lain, MD, MBA, co-chairs of the Science of Skincare Summit, discuss their excitement for the September conference and its innovative educational experience.

The findings highlight new data on AXL expression in inflammatory diseases.

After 4 weeks of daily use, 92% of participants showed an improvement in skin hydration.

The procedure was both effective and safe in a small cohort of patients with refractory hidradenitis suppurativa of the axilla.

As Hair Loss Awareness Month 2023 comes to a close, Dermatology Times is reviewing the top hair loss headlines and news from August.

Learn more about the in-depth topics covered in the August 2023 issue of Dermatology Times.

Research continues to show that food plays a large role in skin diseases.

From its clinical study, 97% of patients saw improvement in acne scars after 3 treatment sessions.

Image-Guided Superficial Radiation Therapy kills cancer cells without surgery.

Allergan Aesthetics has shared details of a recently-published analysis involving patient-reported satisfaction, including natural-looking outcomes, with OnabotulinumtoxinA (Botox) treatment.

In this week’s Pointers With Portela, the 208SkinDoc asks consumers skin health and skin care trivia questions about adequate sleep, SPF reapplication, melasma, and more.

As Psoriasis Awareness Month 2023 comes to a close, Dermatology Times is reviewing the top psoriasis headlines and news from August.

Researchers found an association between ADHD and three inflammatory conditions—atopic dermatitis, otitis media, and herpes simplex infection.

The post hoc analysis published in JAMA Dermatology studied the safety and efficacy of tralokinumab in adults aged 65 and older.

The American Acne and Rosacea Society selected Bunick’s research on tetracycline-class compounds for the award.

The treated areas remained clear up to 18 months after treatment with follicular unit excision.

Investigators recommended further studies exploring the confounding variables that may contribute to higher rates of skin cancers in this patient population.

There are simple tools that can help us achieve the best employment contract.

Click here to answer this week's melasma poll.

Patients with psoriasis treated with IL-23i and IL-17i had a decreased risk of developing pneumonia, otitis media, and upper respiratory tract infections.